April 27, 2020
Hospitals promote need for plasma donations from recovered COVID-19 individuals to potentially help critically ill patients
Tallahasse,Florida – HCA Healthcare North Florida Division Hospitals from the panhandle to Central Florida announced today that they are participating in a national study to determine if plasma from convalescent, or recovered, COVID-19 patients may benefit individuals currently hospitalized with severe or life-threatening cases of the virus. People who tested positive for COVID-19 and have since tested negative can help by donating plasma through the American Red Cross or another local donation center. As part of the effort, the following hospitals are participating in the study and promoting the need for eligible volunteers to donate plasma.
HCA Healthcare North Florida Division hospitals include:
- Capital Regional Medical Center
- Central Florida Regional Hospital
- Fort Walton Beach Medical Center
- Gulf Coast Regional Medical Center
- Lake City Medical Center
- North Florida Regional Medical Center
- Ocala Regional Medical Center
- Osceola Regional Medical Center
- Oviedo Medical Center
- Poinciana Medical Center
- Putnam Community Medical Center
- Twin Cities Hospital
- West Florida Hospital
To date, there is no proven therapy for individuals who are diagnosed with COVID-19, but there is a long history of successful viral infection treatment using convalescent plasma. After someone is infected with a virus like COVID-19 and recovers, their blood contains antibodies that their immune system produced to help them fight off the virus. By infusing this plasma into patients who are facing severe cases of COVID-19, their immune system might more effectively be able to fight the virus. Recent examples of this approach have occurred during outbreaks of coronaviruses like SARS-1, and Middle East Respiratory Syndrome (MERS), but additional clinical data – and more plasma donations – are needed to determine efficacy in treating COVID-19.
The success of the study hinges on the continued collection of plasma from recovered COVID-19 patients. To find out more about the donation process, eligibility and locations to donate, please call HCA Healthcare’s dedicated COVID-19 Plasma Phone Line at (833) 582-1971 or visit the website of your nearest HCA Healthcare hospital.
HCA Healthcare North Florida Division hospitals are part of a network of 172 hospitals participating from the HCA Healthcare network. HCA Healthcare, along with its Sarah Cannon Research Institute, is leveraging its clinical research capabilities and national hospital network to quickly expand collection and testing for this study, which is being led by the Mayo Clinic and supported by the U.S. Food and Drug Administration. This is one of several research initiatives involving COVID-19 in which HCA Healthcare and Sarah Cannon are participating.
About HCA Healthcare North Florida Division
The HCA Healthcare North Florida Division is a comprehensive network of 14 hospitals, numerous outpatient surgery centers & imaging facilities, physician practices, medical education training programs and a complete continuum of specialized health programs and services that meet the healthcare needs of residents and businesses in the North Florida and Central Florida communities. HCA Healthcare North Florida physicians and employees continue to provide the quality foundation for delivering care to our patients safely, effectively and compassionately. Its hospitals are Joint Commission Accredited, with designations such as Accredited Chest Pain Centers, Primary Stroke Center Certification and four Level II Trauma Centers in Marion, Okaloosa, Osceola and Seminole county.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services, comprising 185 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 21 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44 percent. HCA Healthcare is a learning health system that uses its more than 35 million annual patient encounters to advance science, improve patient care and save lives. Connect with HCA Healthcare on social media.
About Sarah Cannon
Sarah Cannon Research Institute is one of the world’s leading clinical research organizations conducting community-based clinical trials. A leader in drug development, Sarah Cannon has led more than 400 first-in-human oncology clinical trials since its inception in 1993 and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Beyond cancer, Sarah Cannon has a dedicated team of experts leading HCA Healthcare’s clinical research platform in many other critical therapeutic areas. To learn more about Sarah Cannon, visit Sarah Cannon's website.